ARTELO BIOSCIENCES, INC. Earnings Per Share (Basic)
ARTELO BIOSCIENCES, INC. (ARTL) reported Earnings Per Share (Basic) of -$0.40 per share for the 3-month period ending 2020-02-29, per its 10-Q filed 2020-04-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2020-04-13
- ARTELO BIOSCIENCES, INC. earnings per share, basic for the quarter ending 2020-02-29 was -$0.40.
- ARTELO BIOSCIENCES, INC. earnings per share, basic for the quarter ending 2019-11-30 was -$0.39.
- ARTELO BIOSCIENCES, INC. earnings per share, basic for the quarter ending 2019-08-31 was -$0.28.
- ARTELO BIOSCIENCES, INC. earnings per share, basic for the quarter ending 2019-05-31 was -$0.17.
- ARTELO BIOSCIENCES, INC. earnings per share, basic for fiscal 2019 was -$1.00.
- ARTELO BIOSCIENCES, INC. earnings per share, basic for fiscal 2018 was -$1.84.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|
| 2020-02-29 | -$0.40 10-Q · filed 2020-04-13 | -$0.79 10-Q · filed 2020-04-13 | -$1.08 derived: net income ÷ weighted average shares · filed 2021-07-12 | -$1.31 derived: net income ÷ weighted average shares · filed 2021-07-12 | ||
| 2019-11-30 | -$0.39 10-Q · filed 2020-01-14 | -$0.68 derived: net income ÷ weighted average shares · filed 2021-07-12 | -$0.89 derived: net income ÷ weighted average shares · filed 2021-07-12 | -$1.13 derived: net income ÷ weighted average shares · filed 2021-07-12 | ||
| 2019-08-31 | -$0.28 derived: net income ÷ weighted average shares · filed 2020-11-04 | -$0.47 derived: net income ÷ weighted average shares · filed 2020-11-04 | -$0.70 derived: net income ÷ weighted average shares · filed 2020-11-04 | -$1.00 10-K/A · filed 2019-12-18 | ||
| 2019-05-31 | -$0.17 10-Q · filed 2019-07-15 | -$0.39 derived: net income ÷ weighted average shares · filed 2020-07-13 | -$0.70 10-Q · filed 2019-07-15 | -$1.27 derived: net income ÷ weighted average shares · filed 2020-07-13 | ||
| 2019-02-28 | -$0.22 10-Q · filed 2020-04-13 | -$0.03 10-Q · filed 2019-04-15 | -$0.53 10-Q · filed 2020-04-13 | -$0.07 10-Q · filed 2019-04-15 | -$1.17 derived: net income ÷ weighted average shares · filed 2020-07-13 | -$1.53 derived: net income ÷ weighted average shares · filed 2020-07-13 |
| 2018-11-30 | -$0.32 10-Q · filed 2020-01-14 | -$1.05 derived: net income ÷ weighted average shares · filed 2020-07-13 | -$1.38 derived: net income ÷ weighted average shares · filed 2020-07-13 | |||
| 2018-08-31 | -$1.10 derived: net income ÷ weighted average shares · filed 2019-12-18 | -$1.14 derived: net income ÷ weighted average shares · filed 2019-12-18 | -$1.84 10-K/A · filed 2019-12-18 | |||
| 2018-05-31 | -$0.36 10-Q · filed 2019-07-15 | -$1.11 10-Q · filed 2019-07-15 | ||||
| 2018-02-28 | -$0.07 10-Q · filed 2019-04-15 | -$0.10 10-Q · filed 2019-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |